Key Takeaways Tariffs under President Trump’s administration in 2025 have expanded in function, stretching beyond trade balance to encompass national security and political strategy. High tariffs—up to 125% on Chinese...
Key Takeaways The Pentagon has maintained restrictions on Ukraine’s use of long-range U.S. missiles against Russian territory, influencing both military strategy and defence-sector demand. Prolonged limitations may contribute to higher...
Key Takeaways Duolingo processes approximately 1.3 billion lessons daily, giving it a substantial advantage in AI-driven language education through vast, proprietary user data. The company launched 148 new language courses...
Key Takeaways The potential cessation of multiple armed conflicts could significantly impact defence budgets, particularly in the US, where military spending reached approximately $849.8 billion in FY2024. While defence stocks...
Key Takeaways Value investing hinges on identifying securities priced below intrinsic value, requiring rigorous analysis and long-term patience. Historical data from 1926–2020 shows value stocks outperformed broader markets, delivering annual...
Key Takeaways Surveys in 2025 suggest many Americans view 58 as the ideal retirement age, though actual retirement averages closer to 65. Economic factors such as inflation, debt, and rising...
Key Takeaways Federal Reserve Chair Jerome Powell’s remarks have hinted at potential rate cuts, with market expectations favouring a September 2025 move. Labour market data shows signs of weakness, with...
Key Takeaways Opera’s Q2 2025 revenue reached $143 million, reflecting a 30% YoY increase, primarily driven by growth in advertising revenue. AI integration through tools like Aria has contributed to...
Key Takeaways NerdWallet reported Q1 2025 revenue of $209.2 million, a 29% year-over-year increase, reflecting strong platform engagement despite a high-rate climate. Lower interest rates forecasted for late 2025 may...
Key Takeaways Undercovered stocks with fewer than 10 analysts often outperform by delaying price discovery, creating an exploitable asymmetry. In Q2 2025, several such names—including Pfizer, DraftKings, and Santacruz Silver...
